Avalyn Publishes Phase 1 Data Highlighting AP02’s Lung-Targeted Delivery and Encouraging Safety Profile
Unusual Whales
The latest findings support Avalyn's strategy of administering known antifibrotic drugs directly to the lungs for increased local impact, reducing systemic exposure, and enhancing tolerance.
